Accelerate Diagnostics reports Q4 results
- Accelerate Diagnostics press release (NASDAQ:AXDX): Q4 GAAP EPS of -$0.34.
- Revenue of $3.3M (+6.5% Y/Y).
Recommended For You
Comments
Have a tip? Submit confidentially to our News team. Found a factual error? Report here.